Considering the limited progress of using JAK inhibitor in the clinic, blocking IRAK4 upstream of this pathway offers the possibility for blocking at once TNF and JAK/STAT pathways along with alleviating anti-dsDNA load using only one inhibitor, an approach that may better control SLE and NPSLE. Here, SOAT1 is linked to systemic lupus erythematosus.